Orally Administered Robotic Drug Delivery Capsule Tunnels Through Mucus to Deliver Insulin
One reason that it’s so difficult to deliver large protein drugs orally is that these drugs can’t pass through the mucus barrier that lines the digestive tract. This means that insulin and most other...
Inside Saudi Arabia’s $20 Billion Bet On Longevity Biotechnology – Forbes
A wall mural displays the 2030 Vision logo and Saudi Arabia's Crown Prince Mohammed bin Salman in ... Dhahran, Saudi Arabia, on Thursday, Oct. 4, 2018. Saudi Arabia's Crown Prince Mohammed said the...
Scalable and fully coupled quantum-inspired processor solves optimization problems
Have you ever been faced with a problem where you had to find an optimal solution out of many possible options, such as finding the quickest route to a certain place, considering both distance...
Can Graphite Bio Realize the Promise of CRISPR Gene Editing to Develop One-time Cures?
Josh Lehrer, MD, MPhil, FACC, isCEO at Graphite Bio.
One dose, one cure. Countless researchers with this dream have worked for decades toward developing life-saving medicines for genetic diseases. That’s gene therapy’s goal: to fix...
Novel CRISPR-based method benefits further cancer studies
Researchers have identified a mechanism by which an oncogene commonly activated in cancer patients affects the growth rate of cells. In the future, the findings can help in developing new treatments that could prevent...
High-tech lab in Nigeria could be a game changer in tackling emerging and re-emerging...
Nigeria's Oligo synthesizer laboratory, the first in West Africa, could be a game changer in tackling emerging and re-emerging diseases in the region if harnessed to its full potential, laboratory scientists have said. Oligo...
Danaher’s New Biotechnology Group – Genetic Engineering & Biotechnology News
Danaher’s recent decision to combine two of its companies—Cytiva and Pall Life Sciences—into a biotechnology group was designed to create one entity that covers the bioprocessing workflow from cell culture through drug products. As...
Ending a 50-year mystery, scientists reveal how bacteria can move
University of Virginia School of Medicine researchers and their collaborators have solved a decades-old mystery about how E. coli and other bacteria are able to move.
Credit: Dan Addison | University of Virginia Communications
University of Virginia School...
Targeting Collateral Damage in Cancer Cells May Revolutionize Precision Oncology
While cancer-triggering mutations often inactivate tumor suppressor genes, they also frequently delete genes essential for survival. This causes cancer cells to rely on other genes that function like the essential genes lost as collateral...
New research model enables scientists to test therapeutics for rare neurodegenerative diseases
For the first time, scientists will be able to test therapeutics for a group of rare neurodegenerative diseases that affect infants and young children thanks to a new research model created by scientists at...
